SN BioScience

SN BioScience is a company specializing in the research and development of drug delivery systems for anticancer drugs. Founded by pharmaceutical R&D experts, world-class biopolymer research professors, and clinical professors, SN BioScience has been developing nanoliposome and nanoparticle drug carriers based on pharmacometrics and pharmacokinetics since its inception. The main pipeline includes polymer nanoparticle anticancer drugs (Phase I clinical trials ongoing in China) and albumin nanoparticle anticancer drugs (Phase I IND application).